摘要:
Granules or powders consisting of a compound of formula [I], in which a modal diameter is 80 µm or less, a median diameter is 45 µm or less, and/or, a ratio of (modal diameter) / (median diameter) is 1.7 or less, are preferably used for an electrolyte or the like.
In formula [I], R 1 and R 2 each independently represents a fluoroalkyl group having 1 to 6 carbon atoms, or a fluorine atom, and Y + represents an alkali metal cation or an ammonium cation.
摘要:
The invention relates to a method of preparing lithium bis(fluorosulfonyl)imide, comprising: reacting lithium bis(chlorosulfonyl)imide with an alkali metal fluoride used as a fluorinating agent in a solvent of saturated alkyl carbonate and/or saturated fluoroalkyl carbonate in the presence of a crownether phase transfer catalyst adaptive to the alkali metal fluoride to obtain lithium bis(fluorosulfonyl)imide. The method of preparing lithium bis(fluorosulfonyl)imide according to the invention possesses a simple process route, and industrial manufacture can be realized easily.
摘要:
The invention relates to a new family of discriminating molecules for neutron rays and gamma rays and their preparation method. These molecules are also used in the detection of (X-ray, gamma-ray, electron, proton, ion) radiation, and therefore in the manufacture of instruments for detecting radiation and for industrial or medical dosimetry.
摘要:
A lubricating agent including an ionic liquid formed from a Bronsted acid (HX) and a Bronsted base (B), wherein the Bronsted base has a linear hydrocarbon group having 10 or more carbon atoms and the difference between the pKa value of the Bronsted acid in water and the pKa value of the Bronsted base in water is 12 or more.
摘要:
The present invention provides novel compounds of formula (I) and methods of use thereof. In certain embodiments, the compounds of the invention are useful as nucleocapsid assembly inhibitors. In other embodiments, the compounds of the invention are useful as pregenomic RNA encapsidation inhibitors of Hepatitis B virus (HBV). In yet other embodiments, the compounds of the invention are useful for the treatment of viral infection, including HBV and related viral infections.
摘要:
A reactive ionic liquid to be used as an ionic component that is contained in an ion-containing layer in a transducer arranged in contact with a high-resistance layer as a dielectric layer of the transducer, and is restrained from migrating from the ion-containing layer to the high-resistance layer on application of a voltage is provided. The reactive ionic liquid comprises an ion pair that consists of an anion and a cation. In the reactive ionic liquid, (a) the anion comprises (a1) a reactive group that consists of an alkoxysilyl group and (a2) an anionic group consisting of a carboxylate (-COO - ) group or a sulfonate (-SO 3 - ) group. (b) The cation (b1) consists of an imidazolium, ammonium, pyrrolidinium, morpholinium, or phosphonium cation, and (b2) does not comprise an N-H group or a P-H group.